SMYD3 and hepatocellular carcinoma: Our data revealed that SMYD3 regulated transcriptional repression by selectively associating with the NuRD (MTA1/2) complex to promote tumorigenesis and metastasis, identifying a previously unrecognized mechanism for driving tumorigenesis in HCC.